At a glance
- Ask every mobile screening vendor to confirm that each device in the kit carries FDA and/or CE clearance, per MP Check's published statement.
- Clearance covers the instrument, not the whole service: also vet validation partners, sample type, on-site interpretation and results handling.
- MP Check runs clinical screening tests at the home or office using finger-prick capillary blood, with no fasting required.
- Screening flags areas worth following up before symptoms appear; it never replaces diagnosis by a treating physician.
MP Check
Published:
Corporate Wellness Programs: A Checklist for Vetting FDA/CE Devices in Mobile Screening Kits
Before you approve a mobile screening vendor for a corporate wellness program, ask for a device-by-device list of the kit's instruments and written confirmation that each one carries FDA and/or CE clearance — MP Check states that every device it uses holds FDA and/or CE approval. Then go one step further: regulatory clearance applies to the instrument, so a wellness-benefit owner still needs to check who validated the kit clinically, what sample the kit takes, how results are interpreted, and where the data lands afterwards. A kit can be assembled entirely from cleared analysers and still deliver a poor screening benefit if the sampling method frightens employees away, if results take weeks, or if nobody qualified explains the numbers on the spot.
That distinction matters because a screening test — a preventive test performed on a healthy person to flag areas worth monitoring and catch problems before symptoms appear — only adds value to a wellness program if employees actually take it. MP Check is Israel's mobile medical screening service, bringing clinically validated early-detection tests to the home or the office using capillary blood drawn from a finger prick rather than a venous draw, with most tests requiring no fasting and most results read on site. MP Check technology is integrated into Sheba Medical Center's "Beyond" virtual hospital, where test results flow into a dedicated system at Sheba connected to the patient's medical record. The checklist that follows sets out what an HR or wellness lead should verify, in what order, and where a mobile kit is the wrong tool for the job.
What should a vetting checklist for devices in a mobile screening kit actually cover?
A vetting checklist for the devices that enter a mobile screening kit is attribute-by-attribute work: each instrument is assessed on its own documented properties before it is allowed to travel to a home or an office. Screening — preventive testing on a person with no symptoms, which flags areas to follow up rather than diagnosing disease — sets the standard each item must meet, because there is no hospital laboratory behind the operator at the point of use.
| Attribute | What the checklist records | Why it matters in a mobile kit |
|---|---|---|
| Regulatory status | Marketing clearance in the applicable regime: FDA clearance in the United States, CE marking under the European conformity framework, or both | Establishes that the instrument's performance claims were reviewed by a regulator before field use |
| Intended-use statement | Cleared for screening or triage versus diagnostic confirmation | A screening result routes the person onward to a treating physician; it never substitutes for one |
| Sample type | Capillary blood from a fingertip prick, venous draw, urine, or non-invasive measurement | Capillary sampling removes the vein puncture and the needle anxiety that keeps many people away from testing |
| Preparation requirement | Fasting required or not required | A no-fasting instrument can be run mid-workday at an employer site |
| Measuring range and reportable limits | Stated analytical range, detection limits, and flagged-result thresholds | Defines which findings the kit can report and which require escalation |
| Quality control and calibration | Built-in controls, lot verification, calibration interval | Field conditions offer no laboratory to re-run a questionable result |
| Transport and environment tolerance | Temperature, humidity, and vibration limits from the manufacturer | Kits move by vehicle across the country, including peripheral areas |
Result destination belongs on the same list. In MP Check's integration with the Beyond virtual hospital of Sheba Medical Center, results flow into a dedicated Sheba system connected to the patient's medical record.
Which regulatory terms do you need to define before you start vetting?
Vetting a mobile screening kit starts with regulatory vocabulary, because the terms procurement teams need most are the ones most often used loosely. Two distinct meanings circulate under the phrase "FDA approved," and sorting them out before you open a vendor questionnaire saves a round of clarification later.
The colloquial umbrella meaning. In everyday buyer language, "FDA approved" is shorthand for "legally marketed in the United States." A finger-prick analyser sold in the US may sit under this umbrella without ever having gone through a premarket approval application.
The narrow regulatory meaning. In the regulator's own language, approval refers specifically to premarket approval, the pathway reserved for the highest-risk class of devices. Clearance is a separate route: a 510(k) premarket notification demonstrating substantial equivalence to a legally marketed predicate device. Most point-of-care chemistry and haematology analysers travel the clearance route.
This section uses the narrow regulatory sense throughout, so "cleared" and "approved" are treated as different statements about a device.
The remaining terms you should define before evaluation:
- CE marking under EU MDR — a declaration of conformity with Regulation (EU) 2017/745, usually supported by a notified body certificate for anything above the lowest risk class.
- Intended use — the manufacturer's stated purpose for the device, which determines whether results may be used for screening or for diagnosis.
- Indications for use — the specific populations, conditions and sample types the device was validated against, including capillary (finger-prick) blood rather than venous draw only.
- Risk class — the I/II/III tiering that dictates how much evidence sat behind clearance or certification.
- UDI — the Unique Device Identification code that lets you verify the exact model and version physically present in a kit against the registration record.
How do FDA clearance and CE marking differ when you evaluate the same screening device?
FDA clearance and CE marking both indicate that a screening device has been assessed against a recognised safety and performance regime, but they are issued by different actors under different evidence rules — so an instrument in a mobile kit may hold one, the other, or both. Before comparing them, fix the criteria you will judge against, because each one becomes decisive in a different procurement situation.
- Evidence expectation — what the manufacturer had to demonstrate before marketing. Decisive when the device measures a clinically actionable parameter.
- Documentation trail — what artefact you can actually ask to see and verify. Decisive for a benefits or procurement lead who must file evidence internally.
- Market scope — the territory in which the authorisation has legal force. Decisive when a kit mixes instruments sourced from different regions.
- Ongoing obligations — what the manufacturer must keep doing after launch. Decisive for multi-year supplier contracts.
| Pathway | Evidence expectation | Documentation trail | Market scope | Ongoing obligations |
|---|---|---|---|---|
| FDA clearance (United States) | Premarket notification (510(k)) showing substantial equivalence to a legally marketed predicate device; higher-risk classes require premarket approval | Clearance letter and indications-for-use statement; entry in the FDA public device databases | United States | Establishment registration, device listing, quality-system compliance, adverse-event reporting |
| CE marking (European Union) | Conformity assessment against the general safety and performance requirements of the EU MDR or IVDR, with notified-body involvement above the lowest risk classes | Manufacturer's declaration of conformity, notified-body certificate, technical file and clinical or performance evaluation | European Economic Area | Post-market surveillance plan, vigilance reporting, UDI and EUDAMED registration |
When you vet a kit that visits the workplace, as with an MP Check session run on site, request the marking per instrument and per model number, and read the intended-use wording: a clearance or certificate covers a defined configuration and a defined purpose, and screening use sits within that stated purpose.
Which documents and records should you request from a supplier before a device enters the kit?
Before a device enters a mobile screening kit, request a complete evidence pack from the supplier and keep those documents as controlled records for the working life of the unit. A screening visit at a home or a company office carries no hospital document room behind it, so the operator holds the archive and the paperwork has to travel with the analyzers that produce the results.
| Document to request | What it evidences | How to archive it |
|---|---|---|
| Declaration of conformity | The manufacturer's signed statement that the device meets the applicable European requirements, naming the regulation and any notified body involved | Dated PDF, tied to model and revision |
| Clearance or certificate reference | The identifier that lets a reviewer confirm the device in the regulator's public listing | Reference number plus date of verification |
| Instructions for use | Intended use, validated specimen type and stated limitations — including whether capillary blood, drawn from a finger prick rather than a vein, is a validated sample | Current revision; supersede, never delete |
| Labeling and identifiers | Lot numbers and unique device identifier, so a field safety notice can be matched to the exact unit in a kit | Serial-level register per kit |
| Quality system evidence | An audit certificate for the manufacturer's quality management system | Renewal date tracked with expiry alerts |
| Post-market contacts | Named vigilance and complaint channel, plus the distribution list for safety notices | Contact sheet reviewed at each re-order |
Records also have to reach the clinical side: ask the vendor to name the clinical system that receives results and the physician who reviews them.
How do you confirm that a device's authorized intended use matches your screening protocol?
To confirm that a device's authorized intended use fits your screening protocol, first separate the two things the word "authorized" is doing in this conversation, because operators routinely conflate them.
Regulatory authorized use is the indications-for-use statement carried in an FDA clearance file or in the CE technical documentation: the specific analyte the instrument measures, the population it was validated in, the sample matrix it accepts, and the setting and operator class it was assessed for. A reader-friendly example: an instrument may be authorized for lipid measurement in adults from capillary whole blood in a professional near-patient setting.
Protocol scope is what your own screening programme — a preventive check offered to people with no symptoms, intended to flag areas worth following up rather than to diagnose — actually asks the kit to do on the day: which participants, which sample, which result pathway.
If the first does not fully contain the second, the panel is being run outside the terms the device was assessed under. This means the verification work is a containment check, item by item:
| Check | What to compare | Failure signal |
|---|---|---|
| Analyte and claim | Measurand plus "screening" versus "monitoring" wording | Claim narrower than protocol |
| Target population | Age range, sex, pregnancy, pediatric exclusions | Participants outside validated group |
| Sample type | Capillary fingerstick versus venous serum or plasma | Matrix substitution |
| Setting and operator | Professional near-patient use versus laboratory-only | Untrained operator or unsuitable environment |
Where a gap appears, narrow the protocol to the authorized population and matrix, exclude the parameter from the mobile panel, and route the participant onward to their treating physician for the test the kit is not authorized to perform. MP Check builds its panels around capillary finger-prick sampling and a questionnaire-based protocol that recommends only the tests each person needs, which gives the matching step a defined sample type and a defined test list to compare against.
Frequently Asked Questions
What does an FDA clearance or CE mark on a mobile screening device actually certify?
An FDA clearance or CE mark certifies that a specific device model meets a regulatory authority's requirements for safety and analytical performance within a declared intended use. It is a statement about the instrument, not about the technician operating it, the sampling method used in the field, or the clinical judgement applied to the result. When vetting a mobile screening kit — a portable set of diagnostic instruments brought to a home or workplace — treat the mark as the entry ticket rather than the whole answer. As published on mpcheckhealth.com, every device MP Check uses in its mobile kit carries FDA and/or CE approval.
How can a buyer verify certification claims without device brand names?
Vendors often withhold instrument brand names for commercial reasons, so build the verification around evidence a vendor can supply without them:
- Certification documentation for each device category in the kit (haematology, urinalysis, cardiac function, and so on).
- Confirmation that the declared intended use covers screening in a non-clinic setting.
- The calibration and quality-control routine applied before each deployment.
- Named clinical governance: who signs off on the protocol and who reviews results.
- Where results are stored and how they reach the participant's own physician.
A buyer running a vendor review in 2026 can request all five in writing without ever seeing a model number.
Why does capillary sampling change what you need to check?
Capillary blood is blood taken from a fingertip rather than from a vein, using only a few drops. The vetting consequence is specific: a device cleared for venous specimens is not automatically appropriate for fingertip ones. Ask the vendor to confirm that each assay in the panel is validated for capillary specimens, and which of the tests being offered require fasting.
Does a certified device mean the result counts as a diagnosis?
No. A screening test is a preventive check performed on a person who feels well; it flags areas worth following up and can surface issues before symptoms appear. It does not diagnose. MP Check performs screening and routes participants onward — most results are interpreted on the spot, including a summary conversation with a specialist physician, and anything requiring follow-up goes to the person's treating doctor. Any vendor presenting a screening output as a diagnosis should fail your review on that point alone.
What is the difference between a certified device and a hospital-validated kit?
Certification is a regulatory status granted to a device model. Hospital validation means the assembled kit and its protocol have been assessed against a medical centre's own clinical standards — a higher bar, because it covers the combination rather than the parts. MP Check's full screening process is validated by Sheba Medical Center.
Which questions belong in an HR or insurer RFP for mobile screening?
- Which certifications cover each device category, and for which sample type?
- How broad is the panel in a single visit? MP Check reports on its site a basket of more than 30 medical parameters in one visit, wider than traditional providers' blood, urine, and cardiac-function panels.
- Is the protocol tailored per participant through a questionnaire, or identical for everyone?
- Does coverage extend beyond the centre to peripheral regions and distributed offices?
- Does the employer receive an anonymised aggregate health dashboard usable as evidence for ESG or B Corporation reporting?
- Does the screening qualify under the periodic screening or preventive medicine clause of participants' private health insurance policies?
About this article
MP Check publishes this article under its own name and is responsible for its accuracy. Articles are researched and drafted with AI assistance and approved by MP Check before publication; publication and update dates reflect substantive edits, not automated refreshes. Last updated: 2026-09-28